Clinical trial
A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
NCT00420459 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00420459 |
|---|---|
| Title | A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome |
| Official title | Aripiprazole in Fragile X Syndrome |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fragile X Syndrome |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 12 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jan 11, 2007 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: